Skip to main content

Table 4 Median (range) dosimetric results for planning target volumes

From: Dosimetric comparison between helical tomotherapy and volumetric modulated arc-therapy for non-anaplastic thyroid cancer treatment

PTV

Dosimetric parameters

VMAT

Helical Tomotherapy

P

PTV 63

D2% (Gy)

65.4 (64.2-67.0)

64.9 (64.1-66.0)

0.131

 

D50% (Gy)

63 (63.0-63.9)

62.9 (62.8-63.1)

0.062

 

D98% (Gy)

58.4 (57.4-60.7)

59.3 (57.0-60.7)

0.248

 

TCov-I

0.94 (0.90-0.99)

0.96 (0.91-0.99)

0.091

 

HTConf-I

0.85 (0.77-0.92)

0.77 (0.66-0.94)

0.016*

 

CN

0.78 (0.76-0.87)

0.74 (0.62-0.85)

0.033*

 

DSC

0.88 (0.87-0.93)

0.85 (0.77-0.92)

0.033*

 

HI

0.11 (0.06-0.15)

0.09 (0.05-0.13)

0.109

PTV 54

D2% (Gy)

64.9 (56.3-66.4)

64.3 (55.0-65.7)

0.109

 

D50% (Gy)

57.5 (54.0-62.3)

57.1 (54.0-61.9)

0.168

 

D98% (Gy)

51.0 (48.6-52.0)

51.8 (50.5-53.6)

0.016*

 

TCov-I

0.97 (0.90-0.99)

0.99 (0.97-1.00)

0.008*

 

HTConf-I

0.84 (0.71-0.89)

0.63 (0.51-0.69)

0.003*

 

CN

0.76 (0.69-0.82)

0.62 (0.50-0.67)

0.003*

 

DSC

0.86 (0.78-0.90)

0.77 (0.67-0.81)

0.003*

 

HI

0.25 (0.12-0.29)

0.22 (0.06-0.26)

0.016*

  1. TCov-I = Target Coverage Index; HTConf-I = Healthy Tissue Conformity Index; CN = Conformation Number; DSC = Dice Similarity Coefficient; HI = Homogeneity Index; * = p < 0.05.